- Home
- TPCS vs OMGA Comparison
TPCS vs OMGA Comparison
Compare TPCS & OMGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPCS
- OMGA
- Stock Information
- Founded
- TPCS 1956
- OMGA 2017
- Country
- TPCS United States
- OMGA United States
- Employees
- TPCS N/A
- OMGA N/A
- Industry
- TPCS Metal Fabrications
- OMGA Biotechnology: Pharmaceutical Preparations
- Sector
- TPCS Industrials
- OMGA Health Care
- Exchange
- TPCS Nasdaq
- OMGA Nasdaq
- Market Cap
- TPCS 31.5M
- OMGA 27.1M
- IPO Year
- TPCS N/A
- OMGA 2021
- Fundamental
- Price
- TPCS $3.20
- OMGA $0.15
- Analyst Decision
- TPCS
- OMGA Strong Buy
- Analyst Count
- TPCS 0
- OMGA 5
- Target Price
- TPCS N/A
- OMGA $9.20
- AVG Volume (30 Days)
- TPCS 25.4K
- OMGA 1.2M
- Earning Date
- TPCS 01-21-2025
- OMGA 03-27-2025
- Dividend Yield
- TPCS N/A
- OMGA N/A
- EPS Growth
- TPCS N/A
- OMGA N/A
- EPS
- TPCS N/A
- OMGA N/A
- Revenue
- TPCS $33,182,059.00
- OMGA $8,095,000.00
- Revenue This Year
- TPCS N/A
- OMGA $181.38
- Revenue Next Year
- TPCS N/A
- OMGA N/A
- P/E Ratio
- TPCS N/A
- OMGA N/A
- Revenue Growth
- TPCS 6.44
- OMGA 185.04
- 52 Week Low
- TPCS $2.85
- OMGA $0.14
- 52 Week High
- TPCS $5.95
- OMGA $4.46
- Technical
- Relative Strength Index (RSI)
- TPCS 46.13
- OMGA 19.88
- Support Level
- TPCS $3.06
- OMGA $0.44
- Resistance Level
- TPCS $3.25
- OMGA $0.54
- Average True Range (ATR)
- TPCS 0.14
- OMGA 0.09
- MACD
- TPCS 0.00
- OMGA -0.02
- Stochastic Oscillator
- TPCS 50.00
- OMGA 2.09
About TPCS TechPrecision Corporation Common stock
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.
About OMGA Omega Therapeutics Inc.
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.